ScholarIQanswers from OpenAlex & ORCID
Esteban Porrini
ResearcherPublications, citations & collaboration network
Esteban Porrini is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Esteban Porrini have?
ScholarIQindexed works
Esteban Porrini has 183 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Esteban Porrini have?
ScholarIQcitation count
Esteban Porrini has 37,897 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Esteban Porrini?
ScholarIQh-index
Esteban Porrini has an h-index of 36 in OpenAlex.
What is the i10-index of Esteban Porrini?
ScholarIQi10-index
Esteban Porrini has an i10-index of 77 in OpenAlex.
What is the ORCID of Esteban Porrini?
ScholarIQorcid
The ORCID for Esteban Porrini is on the source record.
What is the OpenAlex record for Esteban Porrini?
ScholarIQopenalex
The OpenAlex for Esteban Porrini is on the source record.
What are the most-cited papers on Esteban Porrini?
ScholarIQmost cited works
Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
Adnan Sharif, Manfred Hecking, Aiko P. J. de Vries, Esteban Porrini, Mads Hornum, Susanne Rasoul‐Rockenschaub, Gabriela Berlakovich, Michael Krebs, Alexandra Kautzky‐Willer, G. Schernthaner, Piero Marchetti, Giovanni Pacini, Akinlolu Ojo, S. Takahara, Jennifer L. Larsen, Klemens Budde, Kathrin Eller, Julio Pascual, Alan G. Jardine, S.J.L. Bakker, Tone Gretland Valderhaug, Trond Jenssen, S. Cohney, Marcus D. Säemann
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease
Aiko P. J. de Vries, Piero Ruggenenti, Xiong Z. Ruan, Manuel Praga, Josep M. Cruzado, Ingeborg M. Bajema, Vivette D. D’Agati, Hildo J. Lamb, Draženka Pongrac Barlovič, Radovan Hojs, Manuela Abbate, Rosa Rodriquez, Carl Erik Mogensen, Esteban Porrini
Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes
Esteban Porrini, Piero Ruggenenti, Carl Erik Mogensen, Draženka Pongrac Barlovič, Manuel Praga, Josep M. Cruzado, Radovan Hojs, Manuela Abbate, Aiko P. J. de Vries
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA
Pantelis Sarafidis, Charles J. Ferro, Enrique Morales, Alberto Ortíz, Jolanta Małyszko, Radovan Hojs, Khaled Khazim, Robert Ekart, José Manuel Valdivielso, Denis Fouque, Gérard M. London, Ziad A. Massy, P. Ruggenenti, Esteban Porrini, Andrzej Więcek, Carmine Zoccali, Francesca Mallamaci, Mads Hornum